Neonatal Fc Receptor Blockers + Eculizumab Aagh Interaction

Moderateinteraction on record

Description

Concomitant use may lower systemic exposures and reduce effectiveness of eculizumab. Closely monitor for reduced effectiveness.

Mechanism

Reduced systemic exposure of eculizumab via FcRn blockade

Source: NLP:eculizumab-aagh